tiprankstipranks
Trending News
More News >
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
Hong Kong Market

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Revenue

Compare
2 Followers

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Revenue

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H had a revenue of 105.78M in the quarter ending Jun 30, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 423.65M, Decreased 1.51%. In the fiscal year ending Dec 31, 2024, Tianjin TEDA Biomedical Engineering Co. Ltd. Class H had annual revenue of 385.48M with -3.14% growth.
Revenue (ttm)
423.65M
Revenue Growth
-4.88%
P/S Ratio
2.88
Revenue/Employee
HK$1,482,624
Employees
260
Market Cap
HK$1.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
385.48M-12.52M-3.14%
Dec 31, 2023
398.00M-51.68M-11.49%
Dec 31, 2022
449.68M-26.71M-5.61%
Dec 31, 2021
476.38M107.03M+28.98%
Dec 31, 2020
369.36M10.60M+2.96%
Dec 31, 2019
358.75M6.85M+1.95%
Dec 31, 2018
351.90M-24.01M-6.39%
Dec 31, 2017
375.91M-13.37M-3.43%
Dec 31, 2016
389.28M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis